Prevalence and correlates of HCV, HVB, and HIV infection among prison inmates and staff, Hungary

Bálint Tresó, Erzsébet Barcsay, Anna Tarján, Gergely Horváth, Ágnes Dencs, Andrea Hettmann, Mária Magdolna Csépai, Zoltán Gyori, Erzsébet Rusvai, M. Takács

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The aim of this national, multicenter, cross-sectional study was to assess the prevalence of hepatitis B (HBV), hepatitis C (HCV), and human immunodeficiency viruses (HIV) among prisoners, and to identify related risk behaviors including injection drug use. Overall, 4,894 inmates from 20 prisons were enrolled. To have a comparison group, prison staff were also asked to take part. Altogether, 1,553 of the 4,894 inmates from seven prisons completed a questionnaire on risk behaviors. According to the survey, 1.5%, 4.9%, and 0.04% of the prisoners were tested positive for HBsAg, anti-HCV and anti-HIV, respectively. These prevalence data are among the lowest reported from prisons worldwide, although comparable to the Central European data. The prevalence of HBV, HCV, and HIV in the Hungarian prison staff was low (0.38%, 0.47%, and 0%, respectively). The rate of HCV infection was significantly higher among inmates who have ever injected drugs (22.5%) than among inmates who reported they had never injected drugs (1.1%). This first prevalence study of illegal drug injection-related viral infections among Hungarian prisoners points out that ever injecting drugs is the main reason for HCV infection among inmates. The opportunity to reach drug users infected with HCV for treatment underlines the importance of screening programs for blood-borne viruses in prisons.

Original languageEnglish
Pages (from-to)108-116
Number of pages9
JournalJournal of Urban Health
Volume89
Issue number1
DOIs
Publication statusPublished - Feb 2012

Fingerprint

Hungary
Prisons
Virus Diseases
correctional institution
HIV
staff
Prisoners
drug
HBV
prisoner
Pharmaceutical Preparations
Risk-Taking
risk behavior
contagious disease
Cross-Sectional Studies
Injections
Hepatitis C
Hepatitis B Surface Antigens
Drug Users
Infection

Keywords

  • HBV
  • HCV
  • HIV
  • Prisoners
  • Risk factors
  • Screening
  • Staff

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Health(social science)
  • Medicine(all)

Cite this

Prevalence and correlates of HCV, HVB, and HIV infection among prison inmates and staff, Hungary. / Tresó, Bálint; Barcsay, Erzsébet; Tarján, Anna; Horváth, Gergely; Dencs, Ágnes; Hettmann, Andrea; Csépai, Mária Magdolna; Gyori, Zoltán; Rusvai, Erzsébet; Takács, M.

In: Journal of Urban Health, Vol. 89, No. 1, 02.2012, p. 108-116.

Research output: Contribution to journalArticle

Tresó, B, Barcsay, E, Tarján, A, Horváth, G, Dencs, Á, Hettmann, A, Csépai, MM, Gyori, Z, Rusvai, E & Takács, M 2012, 'Prevalence and correlates of HCV, HVB, and HIV infection among prison inmates and staff, Hungary', Journal of Urban Health, vol. 89, no. 1, pp. 108-116. https://doi.org/10.1007/s11524-011-9626-x
Tresó, Bálint ; Barcsay, Erzsébet ; Tarján, Anna ; Horváth, Gergely ; Dencs, Ágnes ; Hettmann, Andrea ; Csépai, Mária Magdolna ; Gyori, Zoltán ; Rusvai, Erzsébet ; Takács, M. / Prevalence and correlates of HCV, HVB, and HIV infection among prison inmates and staff, Hungary. In: Journal of Urban Health. 2012 ; Vol. 89, No. 1. pp. 108-116.
@article{9c59d7f5b1f44a18b7466e2bb7801a2b,
title = "Prevalence and correlates of HCV, HVB, and HIV infection among prison inmates and staff, Hungary",
abstract = "The aim of this national, multicenter, cross-sectional study was to assess the prevalence of hepatitis B (HBV), hepatitis C (HCV), and human immunodeficiency viruses (HIV) among prisoners, and to identify related risk behaviors including injection drug use. Overall, 4,894 inmates from 20 prisons were enrolled. To have a comparison group, prison staff were also asked to take part. Altogether, 1,553 of the 4,894 inmates from seven prisons completed a questionnaire on risk behaviors. According to the survey, 1.5{\%}, 4.9{\%}, and 0.04{\%} of the prisoners were tested positive for HBsAg, anti-HCV and anti-HIV, respectively. These prevalence data are among the lowest reported from prisons worldwide, although comparable to the Central European data. The prevalence of HBV, HCV, and HIV in the Hungarian prison staff was low (0.38{\%}, 0.47{\%}, and 0{\%}, respectively). The rate of HCV infection was significantly higher among inmates who have ever injected drugs (22.5{\%}) than among inmates who reported they had never injected drugs (1.1{\%}). This first prevalence study of illegal drug injection-related viral infections among Hungarian prisoners points out that ever injecting drugs is the main reason for HCV infection among inmates. The opportunity to reach drug users infected with HCV for treatment underlines the importance of screening programs for blood-borne viruses in prisons.",
keywords = "HBV, HCV, HIV, Prisoners, Risk factors, Screening, Staff",
author = "B{\'a}lint Tres{\'o} and Erzs{\'e}bet Barcsay and Anna Tarj{\'a}n and Gergely Horv{\'a}th and {\'A}gnes Dencs and Andrea Hettmann and Cs{\'e}pai, {M{\'a}ria Magdolna} and Zolt{\'a}n Gyori and Erzs{\'e}bet Rusvai and M. Tak{\'a}cs",
year = "2012",
month = "2",
doi = "10.1007/s11524-011-9626-x",
language = "English",
volume = "89",
pages = "108--116",
journal = "Journal of Urban Health",
issn = "1099-3460",
publisher = "Springer Science and Business Media Deutschland GmbH",
number = "1",

}

TY - JOUR

T1 - Prevalence and correlates of HCV, HVB, and HIV infection among prison inmates and staff, Hungary

AU - Tresó, Bálint

AU - Barcsay, Erzsébet

AU - Tarján, Anna

AU - Horváth, Gergely

AU - Dencs, Ágnes

AU - Hettmann, Andrea

AU - Csépai, Mária Magdolna

AU - Gyori, Zoltán

AU - Rusvai, Erzsébet

AU - Takács, M.

PY - 2012/2

Y1 - 2012/2

N2 - The aim of this national, multicenter, cross-sectional study was to assess the prevalence of hepatitis B (HBV), hepatitis C (HCV), and human immunodeficiency viruses (HIV) among prisoners, and to identify related risk behaviors including injection drug use. Overall, 4,894 inmates from 20 prisons were enrolled. To have a comparison group, prison staff were also asked to take part. Altogether, 1,553 of the 4,894 inmates from seven prisons completed a questionnaire on risk behaviors. According to the survey, 1.5%, 4.9%, and 0.04% of the prisoners were tested positive for HBsAg, anti-HCV and anti-HIV, respectively. These prevalence data are among the lowest reported from prisons worldwide, although comparable to the Central European data. The prevalence of HBV, HCV, and HIV in the Hungarian prison staff was low (0.38%, 0.47%, and 0%, respectively). The rate of HCV infection was significantly higher among inmates who have ever injected drugs (22.5%) than among inmates who reported they had never injected drugs (1.1%). This first prevalence study of illegal drug injection-related viral infections among Hungarian prisoners points out that ever injecting drugs is the main reason for HCV infection among inmates. The opportunity to reach drug users infected with HCV for treatment underlines the importance of screening programs for blood-borne viruses in prisons.

AB - The aim of this national, multicenter, cross-sectional study was to assess the prevalence of hepatitis B (HBV), hepatitis C (HCV), and human immunodeficiency viruses (HIV) among prisoners, and to identify related risk behaviors including injection drug use. Overall, 4,894 inmates from 20 prisons were enrolled. To have a comparison group, prison staff were also asked to take part. Altogether, 1,553 of the 4,894 inmates from seven prisons completed a questionnaire on risk behaviors. According to the survey, 1.5%, 4.9%, and 0.04% of the prisoners were tested positive for HBsAg, anti-HCV and anti-HIV, respectively. These prevalence data are among the lowest reported from prisons worldwide, although comparable to the Central European data. The prevalence of HBV, HCV, and HIV in the Hungarian prison staff was low (0.38%, 0.47%, and 0%, respectively). The rate of HCV infection was significantly higher among inmates who have ever injected drugs (22.5%) than among inmates who reported they had never injected drugs (1.1%). This first prevalence study of illegal drug injection-related viral infections among Hungarian prisoners points out that ever injecting drugs is the main reason for HCV infection among inmates. The opportunity to reach drug users infected with HCV for treatment underlines the importance of screening programs for blood-borne viruses in prisons.

KW - HBV

KW - HCV

KW - HIV

KW - Prisoners

KW - Risk factors

KW - Screening

KW - Staff

UR - http://www.scopus.com/inward/record.url?scp=84857921974&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857921974&partnerID=8YFLogxK

U2 - 10.1007/s11524-011-9626-x

DO - 10.1007/s11524-011-9626-x

M3 - Article

C2 - 22143408

AN - SCOPUS:84857921974

VL - 89

SP - 108

EP - 116

JO - Journal of Urban Health

JF - Journal of Urban Health

SN - 1099-3460

IS - 1

ER -